Pharmafile Logo

patient expectations

Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?

With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and...

Impetus Digital

Part 3 of the Medscape video series #EHA

Ahead of  Europe’s largest hematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr. Naval Daver on the most important abstracts to look out for in Myeloid and...

Medscape Education

Part 2 of the Medscape video interview series

Ahead of Europe’s largest haematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer interviews Dr. John Gribben on the most important abstracts to look out for in CLL and the...

Medscape Education

Engaging Patients “Just-In-Time” with Machine Learning

Omri Shor, Co-founder & CEO of Medisafe, explores how Pharma companies can use digital therapeutics for advancing and supporting the patient journey, how new digital health tools are driving deeper...

Impetus Digital

- PMLiVE

Sanofi and Regeneron receives FDA priority review for prurigo nodularis

Dupixent would be the first drug specifically indicated for the condition in the US

- PMLiVE

TauRx shares phase 3 trial data for Alzheimer’s drug

Those receiving the drug experienced a significantly slower decline than usual

- PMLiVE

OPEN Health is acquired by Astorg in partnership with Amulet Capital

OPEN Health’s current management team, headed by CEO Rob Barker, will continue to lead the company

Interactive: Best Behaviour

Download our curated collection of case studies and other useful resources that illustrate how we apply the principles of behavioural science in our research design.

Inizio

- PMLiVE

Measurement in Med Comms: Striving for Creative Effectiveness

How to achieve creative success in Med Comms (Article written 6th Jan 2020)

Dice Medical Communications

A person smiling for the cameraDescription automatically generated with medium confidence

Reflections on the MAPS EMEA 2022 Annual Meeting

Amanda Henkel, VP Strategy, Nucleus X Consulting (part of Nucleus Global) shares her thoughts on this year’s meeting.

Nucleus Global

- PMLiVE

Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy

The drug is now approved to treat SMA in children and adults of all ages

- PMLiVE

Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities

The initiative wants to increase the global use of biosimilars by at least 30% by 2030

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links